Day One Biopharmaceuticals develops advanced medicines in the US and appoints Michael Vasconcelles as Head of R&D.
2 reports, 1 independent
Updated Jul 25
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Day One Biopharmaceuticals develops advanced medicines in the US and appoints Michael Vasconcelles as Head of R&D.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Day One Biopharmaceuticals (United States)
company in Brisbane, United States
Nothing else this week.
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.Exploring High Growth Tech Stocks in the US This July 2025 In the last week, the United States market has been flat, but over the past 12 months, it has risen by 18%, with earnings expected to grow b
- Unknown outlet